These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10371028)

  • 21. Localisation of indoleamine 2,3-dioxygenase and kynurenine hydroxylase in the human placenta and decidua: implications for role of the kynurenine pathway in pregnancy.
    Ligam P; Manuelpillai U; Wallace EM; Walker D
    Placenta; 2005 Jul; 26(6):498-504. PubMed ID: 15950064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversible inhibitors of the gastric (H+/K+)-ATPase. 1. 1-Aryl-4-methylpyrrolo[3,2-c]quinolines as conformationally restrained analogues of 4-(arylamino)quinolines.
    Brown TH; Ife RJ; Keeling DJ; Laing SM; Leach CA; Parsons ME; Price CA; Reavill DR; Wiggall KJ
    J Med Chem; 1990 Feb; 33(2):527-33. PubMed ID: 2153816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and pharmacological profile of 1-aryl-3-substituted pyrrolo[3,2-c]quinolines.
    Yum EK; Kang SK; Kim SS; Choi JK; Cheon HG
    Bioorg Med Chem Lett; 1999 Oct; 9(19):2819-22. PubMed ID: 10522698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of the kynurenine pathway in search for new neuroprotective agents. Synthesis and preliminary evaluation of (m-nitrobenzoyl)alanine, a potent inhibitor of kynurenine-3-hydroxylase.
    Pellicciari R; Natalini B; Costantino G; Mahmoud MR; Mattoli L; Sadeghpour BM; Moroni F; Chiarugi A; Carpenedo R
    J Med Chem; 1994 Mar; 37(5):647-55. PubMed ID: 8126705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on antibacterial agents. II. Synthesis and antibacterial activities of substituted 1,2-dihydro-6-oxo-6H-pyrrolo[3,2,1-ij]quinoline-5-carboxylic acids.
    Ishikawa H; Uno T; Miyamoto H; Ueda H; Tamaoka H; Tominaga M; Nakagawa K
    Chem Pharm Bull (Tokyo); 1990 Sep; 38(9):2459-62. PubMed ID: 2126749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, biochemical evaluation and rationalisation of the inhibitory activity of a range of phenyl alkyl imidazole-based compounds as potent inhibitors of the enzyme complex 17alpha-hydroxylase/17,20-lyase (P450(17alpha)).
    Owen CP; Shahid I; Olusanjo MS; Patel CH; Dhanani S; Ahmed S
    J Steroid Biochem Mol Biol; 2008 Jul; 111(1-2):117-27. PubMed ID: 18620055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benzoylalanine analogues as inhibitors of rat brain kynureninase and kynurenine 3-hydroxylase.
    Giordani A; Corti L; Cini M; Marconi M; Pillan A; Ferrario R; Schwarcz R; Guidetti P; Speciale C; Varasi M
    Adv Exp Med Biol; 1996; 398():499-505. PubMed ID: 8906311
    [No Abstract]   [Full Text] [Related]  

  • 28. Pyrrolo[3,2,1-ij]quinoline derivatives, a 5-HT2c receptor agonist with selectivity over the 5-HT2a receptor: potential therapeutic applications for epilepsy and obesity.
    Isaac M; Slassi A; O'Brien A; Edwards L; MacLean N; Bueschkens D; Lee DK; McCallum K; De Lannoy I; Demchyshyn L; Kamboj R
    Bioorg Med Chem Lett; 2000 May; 10(9):919-21. PubMed ID: 10853660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitors of kynurenine hydroxylase and kynureninase increase cerebral formation of kynurenate and have sedative and anticonvulsant activities.
    Carpenedo R; Chiarugi A; Russi P; Lombardi G; Carlà V; Pellicciari R; Mattoli L; Moroni F
    Neuroscience; 1994 Jul; 61(2):237-43. PubMed ID: 7969905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pyrrolo[3,4-c]quinoline-1,3-diones as potent caspase-3 inhibitors. Synthesis and SAR of 2-substituted 4-methyl-8-(morpholine-4-sulfonyl)-pyrrolo[3,4-c]quinoline-1,3-diones.
    Kravchenko DV; Kysil VM; Tkachenko SE; Maliarchouk S; Okun IM; Ivachtchenko AV
    Eur J Med Chem; 2005 Dec; 40(12):1377-83. PubMed ID: 16169127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combinatorial synthesis of pyrrolo[3,2-f]quinoline and pyrrolo[3,2-a]acridine derivatives via a three-component reaction under catalyst-free conditions.
    Zhou YJ; Chen DS; Li YL; Liu Y; Wang XS
    ACS Comb Sci; 2013 Sep; 15(9):498-502. PubMed ID: 23914831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and antiproliferative activity of some new DNA-targeted alkylating pyrroloquinolines.
    Ferlin MG; Dalla Via L; Gia OM
    Bioorg Med Chem; 2004 Feb; 12(4):771-7. PubMed ID: 14759737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence that kynurenine pathway metabolites mediate hyperbaric oxygen-induced convulsions.
    Dale WE; Dang Y; Amiridze N; Brown OR
    Toxicol Lett; 2000 Sep; 117(1-2):37-43. PubMed ID: 11033231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of oxygen on kynurenine-3-monooxygenase activity.
    Dang Y; Dale WE; Brown OR
    Redox Rep; 2000; 5(2-3):81-4. PubMed ID: 10939276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a series of aryl pyrimidine kynurenine monooxygenase inhibitors as potential therapeutic agents for the treatment of Huntington's disease.
    Toledo-Sherman LM; Prime ME; Mrzljak L; Beconi MG; Beresford A; Brookfield FA; Brown CJ; Cardaun I; Courtney SM; Dijkman U; Hamelin-Flegg E; Johnson PD; Kempf V; Lyons K; Matthews K; Mitchell WL; O'Connell C; Pena P; Powell K; Rassoulpour A; Reed L; Reindl W; Selvaratnam S; Friley WW; Weddell DA; Went NE; Wheelan P; Winkler C; Winkler D; Wityak J; Yarnold CJ; Yates D; Munoz-Sanjuan I; Dominguez C
    J Med Chem; 2015 Feb; 58(3):1159-83. PubMed ID: 25590515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pyrroloquinoline scaffold-based 5-HT
    Grychowska K; Kurczab R; Śliwa P; Satała G; Dubiel K; Matłoka M; Moszczyński-Pętkowski R; Pieczykolan J; Bojarski AJ; Zajdel P
    Bioorg Med Chem; 2018 Jul; 26(12):3588-3595. PubMed ID: 29853337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and evaluation of stable bidentate transition metal complexes of 1-(chloromethyl)-5-hydroxy-3-(5,6,7-trimethoxyindol-2-ylcarbonyl)-2,3-dihydro-1H-pyrrolo[3,2-f]quinoline (seco-6-azaCBI-TMI) as hypoxia selective cytotoxins.
    Milbank JB; Stevenson RJ; Ware DC; Chang JY; Tercel M; Ahn GO; Wilson WR; Denny WA
    J Med Chem; 2009 Nov; 52(21):6822-34. PubMed ID: 19821576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mannich bases of 3H-pyrrolo[3,2-f]quinoline having vasorelaxing activity.
    Ferlin MG; Chiarelotto G; Antonucci F; Caparrotta L; Froldi G
    Eur J Med Chem; 2002 May; 37(5):427-34. PubMed ID: 12008057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Facile synthesis of spiro[indoline-3,3'-pyrrolo[1,2-a]quinolines] and spiro[indoline-3,1'-pyrrolo[2,1-a]isoquinolines] via 1,3-dipolar cycloaddition reactions of heteroaromatic ammonium salts with 3-phenacylideneoxindoles.
    Wu L; Sun J; Yan CG
    Org Biomol Chem; 2012 Dec; 10(47):9452-63. PubMed ID: 23117483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New water soluble pyrroloquinoline derivatives as new potential anticancer agents.
    Ferlin MG; Marzano C; Dalla Via L; Chilin A; Zagotto G; Guiotto A; Moro S
    Bioorg Med Chem; 2005 Aug; 13(15):4733-9. PubMed ID: 15936202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.